{
    "clinical_study": {
        "@rank": "117553", 
        "biospec_descr": {
            "textblock": "Whole blood, cerebro-spinal fluid, nasal aspirate"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The aim of this study is to estimate the burden of disease due to pneumococci, other\n      bacteria and viruses in the African meningitis belt. In a defined population of a sanitary\n      district in northern Togo, during the period 2010 to 2013, the investigators enroll patients\n      of all age with suspected pneumonia requiring hospitalisation or suspected bacterial\n      meningitis. Patients are evaluated by bacteriology and molecular biology techniques on\n      blood, cerebro-spinal fluid, nasal aspirates and by chest X-ray."
        }, 
        "brief_title": "Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in T\u00f4ne District, Togo, 2010-2013", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Pneumonia, Bacterial", 
            "Pneumonia, Viral", 
            "Meningitis, Bacterial"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Pneumonia, Bacterial", 
                "Meningitis", 
                "Pneumonia", 
                "Pneumonia, Viral", 
                "Meningitis, Bacterial"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Pneumonia surveillance:\n\n        Inclusion Criteria:\n\n          -  resident of T\u00f4ne sanitary district  - requiring hospitalisation for at least one\n             night for clinical pneumonia syndrome\n\n          -  hospitalised in a study site during the study period\n\n        Exclusion Criteria:\n\n          -  absence of informed consent by patient or legal tutor\n\n        Meningitis surveillance:\n\n        Inclusion Criteria:\n\n          -  resident of T\u00f4ne sanitary district\n\n          -  presenting clinical signs of acute bacterial meningitis\n\n          -  hospitalised in a study site during the study period\n\n        Exclusion Criteria:\n\n          -  absence of informed consent by patient or legal tutor"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Pneumonia surveillance:\n\n        -residents of T\u00f4ne sanitary district requiring hospitaliation for suspected pneumonia and\n        presenting at one of the hospitals of Dapaong town (district capital)\n\n        Meningitis surveillance:\n\n        - residents fo T\u00f4ne sanitary district presenting with suspected meningitis at one of the\n        hospitals of Dapaong town (district capital) or Sinkasse health center"
            }
        }, 
        "enrollment": {
            "#text": "2000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 4, 2011", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01747369", 
            "org_study_id": "PneumoTone"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "surveillance study", 
            "prospective", 
            "observational", 
            "health center-based", 
            "pneumonia, bacterial", 
            "pneumonia, viral", 
            "meningitis, bacterial", 
            "Africa south of the Sahara"
        ], 
        "lastchanged_date": "December 10, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Cinkass\u00e9", 
                        "country": "Togo", 
                        "state": "Savanes region"
                    }, 
                    "name": "Centre m\u00e9dico-social (CMS)"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dapaong", 
                        "country": "Togo", 
                        "state": "Savanes region"
                    }, 
                    "name": "Centre Hospitalier R\u00e9gional (CHR) Savanes"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dapaong", 
                        "country": "Togo", 
                        "state": "Savanes region"
                    }, 
                    "name": "H\u00f4pital d'enfants Yendub\u00e9"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dapaong", 
                        "country": "Togo", 
                        "state": "Savanes region"
                    }, 
                    "name": "Clinique Win' Pang"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dapaong", 
                        "country": "Togo", 
                        "state": "Savanes region"
                    }, 
                    "name": "Polyclinique"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Togo"
        }, 
        "number_of_groups": "1", 
        "overall_contact": {
            "email": "makmaksy@yahoo.fr", 
            "last_name": "Makawa-Sy Makawa, MD", 
            "phone": "+228-921 29 31"
        }, 
        "overall_contact_backup": {
            "email": "htall@aamp.org", 
            "last_name": "Haoua Tall, PharmD MPH", 
            "phone": "+226-50300406"
        }, 
        "overall_official": {
            "affiliation": "Agence de M\u00e9decine Pr\u00e9ventive", 
            "last_name": "Jennifer C Mo\u00efsi, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Togo: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Incidence of pneumococcal pneumonia requiring hospitalisation, confirmed by blood culture or PCR analysis of blood", 
                "safety_issue": "No", 
                "time_frame": "Subjects will be enrolled on admission to hospital and followed for the duration of hospitalization (median duration 6 days)"
            }, 
            {
                "measure": "Incidence of pneumococcal meningitis, confirmed by culture or PCR on cerebro-spinal fluid", 
                "safety_issue": "No", 
                "time_frame": "Subjects will be enrolled on admission to hospital and followed for the duration of hospitalization (median duration 6 days)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01747369"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Incidence of radiologically confirmed pneumonia requiring hospitalisation", 
                "safety_issue": "No", 
                "time_frame": "Subjects will be enrolled on admission to hospital and followed for the duration of hospitalization (median duration 6 days)"
            }, 
            {
                "measure": "Incidence of suspected pneumonia requiring hospitalisation with elevated C-reactive protein serum concentration (<40mg/l)", 
                "safety_issue": "No", 
                "time_frame": "Subjects will be enrolled on admission to hospital and followed for the duration of hospitalization (median duration 6 days)"
            }, 
            {
                "measure": "Incidence of suspected pneumonia requiring hospitalisation with reduced oxygen saturation (<90%)", 
                "safety_issue": "No", 
                "time_frame": "Subjects will be enrolled on admission to hospital and followed for the duration of hospitalization (median duration 6 days)"
            }, 
            {
                "measure": "Incidence of pneumonia of other bacterial or viral etiology requiring hospitalisation", 
                "safety_issue": "No", 
                "time_frame": "Subjects will be enrolled on admission to hospital and followed for the duration of hospitalization (median duration 6 days)"
            }, 
            {
                "measure": "Incidence of acute meningitis of other bacterial etiology", 
                "safety_issue": "No", 
                "time_frame": "Subjects will be enrolled on admission to hospital and followed for the duration of hospitalization (median duration 6 days)"
            }
        ], 
        "source": "Agence de M\u00e9decine Pr\u00e9ventive, France", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Savanes Sanitary Region Togo", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Ministry of Health, Togo", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "National Reference Laboratory for Epidemic Disease Togo", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Centre Muraz", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Fondation M\u00e9rieux", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Pfizer", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "Agence de M\u00e9decine Pr\u00e9ventive, France", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2010", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2012"
    }
}